カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のエドキサバントシル酸塩口腔内崩壊錠市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Edoxaban Tosilate Orally Disintegrating Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7839）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7839
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：75
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のエドキサバントシル酸塩口腔内崩壊錠市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のエドキサバントシル酸塩口腔内崩壊錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のエドキサバントシル酸塩口腔内崩壊錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- エドキサバントシル酸塩口腔内崩壊錠の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

エドキサバントシル酸塩口腔内崩壊錠市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・15mg、30mg、60mg

用途別セグメント
・病院、診療所、その他

主要な市場プレーヤー
・Daiichi Sankyo

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エドキサバントシル酸塩口腔内崩壊錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエドキサバントシル酸塩口腔内崩壊錠メーカーの企業概要、2019年～2022年までのエドキサバントシル酸塩口腔内崩壊錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエドキサバントシル酸塩口腔内崩壊錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別エドキサバントシル酸塩口腔内崩壊錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのエドキサバントシル酸塩口腔内崩壊錠のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのエドキサバントシル酸塩口腔内崩壊錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびエドキサバントシル酸塩口腔内崩壊錠の産業チェーンを掲載しています。
・第14、15章では、エドキサバントシル酸塩口腔内崩壊錠の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– エドキサバントシル酸塩口腔内崩壊錠の概要
– タイプ別分析（2018年vs2022年vs2029年）：15mg、30mg、60mg
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のエドキサバントシル酸塩口腔内崩壊錠市場規模・予測
– 世界のエドキサバントシル酸塩口腔内崩壊錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Daiichi Sankyo
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：15mg、30mg、60mg
・用途別分析2018年-2029年：病院、診療所、その他
・エドキサバントシル酸塩口腔内崩壊錠の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・エドキサバントシル酸塩口腔内崩壊錠のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・エドキサバントシル酸塩口腔内崩壊錠のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エドキサバントシル酸塩口腔内崩壊錠の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・エドキサバントシル酸塩口腔内崩壊錠の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Edoxaban Tosilate Orally Disintegrating Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 15 mg
1.3.3 30 mg
1.3.4 60 mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size & Forecast
1.5.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity (2018-2029)
1.5.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Daiichi Sankyo
2.1.1 Daiichi Sankyo Details
2.1.2 Daiichi Sankyo Major Business
2.1.3 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product and Services
2.1.4 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Daiichi Sankyo Recent Developments/Updates
3 Competitive Environment: Edoxaban Tosilate Orally Disintegrating Tablets by Manufacturer
3.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Edoxaban Tosilate Orally Disintegrating Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Edoxaban Tosilate Orally Disintegrating Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Edoxaban Tosilate Orally Disintegrating Tablets Manufacturer Market Share in 2022
3.5 Edoxaban Tosilate Orally Disintegrating Tablets Market: Overall Company Footprint Analysis
3.5.1 Edoxaban Tosilate Orally Disintegrating Tablets Market: Region Footprint
3.5.2 Edoxaban Tosilate Orally Disintegrating Tablets Market: Company Product Type Footprint
3.5.3 Edoxaban Tosilate Orally Disintegrating Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Region
4.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Region (2018-2029)
4.2 North America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029)
4.3 Europe Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029)
4.5 South America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2029)
5.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Type (2018-2029)
5.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2029)
6.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Application (2018-2029)
6.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2029)
7.2 North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2029)
7.3 North America Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country
7.3.1 North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country
8.3.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Region
9.3.1 Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2029)
10.2 South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2029)
10.3 South America Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country
10.3.1 South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country
11.3.1 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Edoxaban Tosilate Orally Disintegrating Tablets Market Drivers
12.2 Edoxaban Tosilate Orally Disintegrating Tablets Market Restraints
12.3 Edoxaban Tosilate Orally Disintegrating Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Edoxaban Tosilate Orally Disintegrating Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Edoxaban Tosilate Orally Disintegrating Tablets
13.3 Edoxaban Tosilate Orally Disintegrating Tablets Production Process
13.4 Edoxaban Tosilate Orally Disintegrating Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Edoxaban Tosilate Orally Disintegrating Tablets Typical Distributors
14.3 Edoxaban Tosilate Orally Disintegrating Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Major Business
Table 5. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product and Services
Table 6. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Daiichi Sankyo Recent Developments/Updates
Table 8. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 9. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 10. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 11. Market Position of Manufacturers in Edoxaban Tosilate Orally Disintegrating Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 12. Head Office and Edoxaban Tosilate Orally Disintegrating Tablets Production Site of Key Manufacturer
Table 13. Edoxaban Tosilate Orally Disintegrating Tablets Market: Company Product Type Footprint
Table 14. Edoxaban Tosilate Orally Disintegrating Tablets Market: Company Product Application Footprint
Table 15. Edoxaban Tosilate Orally Disintegrating Tablets New Market Entrants and Barriers to Market Entry
Table 16. Edoxaban Tosilate Orally Disintegrating Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 18. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 19. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 20. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 21. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 22. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 23. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 24. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 25. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 26. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 27. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 28. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 29. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 30. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 31. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 32. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 33. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 34. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 35. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 36. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 37. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 38. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 39. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 40. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 41. North America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 42. North America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 43. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 46. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 47. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 48. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 49. Europe Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 50. Europe Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 51. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 52. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 53. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 54. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 55. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 56. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 57. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 58. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 59. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 60. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 61. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 62. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 63. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 64. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 65. South America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 66. South America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 67. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 68. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 69. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 72. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 73. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 74. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 75. Edoxaban Tosilate Orally Disintegrating Tablets Raw Material
Table 76. Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets Raw Materials
Table 77. Edoxaban Tosilate Orally Disintegrating Tablets Typical Distributors
Table 78. Edoxaban Tosilate Orally Disintegrating Tablets Typical Customers
List of Figures
Figure 1. Edoxaban Tosilate Orally Disintegrating Tablets Picture
Figure 2. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Type in 2022
Figure 4. 15 mg Examples
Figure 5. 30 mg Examples
Figure 6. 60 mg Examples
Figure 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Edoxaban Tosilate Orally Disintegrating Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Edoxaban Tosilate Orally Disintegrating Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Edoxaban Tosilate Orally Disintegrating Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Region (2018-2029)
Figure 54. China Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Edoxaban Tosilate Orally Disintegrating Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Edoxaban Tosilate Orally Disintegrating Tablets Market Drivers
Figure 75. Edoxaban Tosilate Orally Disintegrating Tablets Market Restraints
Figure 76. Edoxaban Tosilate Orally Disintegrating Tablets Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Edoxaban Tosilate Orally Disintegrating Tablets in 2022
Figure 79. Manufacturing Process Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 80. Edoxaban Tosilate Orally Disintegrating Tablets Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 口腔内崩壊錠（ODT）のグローバル市場（～2030年）：口腔内崩壊錠、速溶錠、舌下錠、その他
  • 世界のペントキシフィリン徐放性錠剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のビルダグリプチン錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のロバスタチン錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のイバブラジン塩酸塩錠市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7839 )"世界のエドキサバントシル酸塩口腔内崩壊錠市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Edoxaban Tosilate Orally Disintegrating Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。